ClinicalTrials.Veeva

Menu

Age of Red Blood Cells in Premature Infants Study (ARIPI)

O

Ottawa Hospital Research Institute

Status

Completed

Conditions

Premature Birth

Treatments

Biological: Transfusion

Study type

Interventional

Funder types

Other

Identifiers

NCT00326924
2004706-01H

Details and patient eligibility

About

To determine if the age of blood transfused to new borns in the NICU setting has an impact on their outcome.

Enrollment

377 patients

Sex

All

Ages

1 minute to 37 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • birthweight of less than 1250g
  • admitted to participating NICU
  • consent acquired from proxy for the patient

Exclusion criteria

  • already received one or more transfusions
  • requirement for an exchange transfusion
  • will be receiving directed donations
  • have rare blood types/difficult cross-match
  • proxy has refused consent
  • moribund on admission to NICU/expected to die
  • mitigating child protection issues

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

377 participants in 2 patient groups

Biological
Experimental group
Description:
PRBCs that are less than 7 days old are considered 'fresh'.
Treatment:
Biological: Transfusion
Standard PRBCs
Experimental group
Description:
PRBCs 'stored' as per hospital policy.
Treatment:
Biological: Transfusion

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems